SE9202250D0 - Controlled release morphine preparation - Google Patents

Controlled release morphine preparation

Info

Publication number
SE9202250D0
SE9202250D0 SE9202250A SE9202250A SE9202250D0 SE 9202250 D0 SE9202250 D0 SE 9202250D0 SE 9202250 A SE9202250 A SE 9202250A SE 9202250 A SE9202250 A SE 9202250A SE 9202250 D0 SE9202250 D0 SE 9202250D0
Authority
SE
Sweden
Prior art keywords
preparation
morphine
controlled release
essentially
release morphine
Prior art date
Application number
SE9202250A
Other languages
English (en)
Swedish (sv)
Inventor
C Persson
Original Assignee
Gacell Lab Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gacell Lab Ab filed Critical Gacell Lab Ab
Priority to SE9202250A priority Critical patent/SE9202250D0/xx
Publication of SE9202250D0 publication Critical patent/SE9202250D0/xx
Priority to IL10647793A priority patent/IL106477A/en
Priority to HU9500260A priority patent/HU221683B1/hu
Priority to AU45955/93A priority patent/AU662239B2/en
Priority to DE69323428T priority patent/DE69323428T2/de
Priority to AT93916380T priority patent/ATE176398T1/de
Priority to CA002140254A priority patent/CA2140254C/en
Priority to ES93916380T priority patent/ES2130278T3/es
Priority to NZ254314A priority patent/NZ254314A/en
Priority to PL93307262A priority patent/PL172571B1/pl
Priority to JP6505225A priority patent/JPH08501081A/ja
Priority to PCT/SE1993/000642 priority patent/WO1994003161A1/en
Priority to EP93916380A priority patent/EP0652747B1/en
Priority to DK93916380T priority patent/DK0652747T3/da
Priority to RU95105449A priority patent/RU2114613C1/ru
Priority to KR1019950700300A priority patent/KR0156038B1/ko
Priority to CN93118344A priority patent/CN1053339C/zh
Priority to ZA935488A priority patent/ZA935488B/xx
Priority to US08/362,526 priority patent/US5520931A/en
Priority to FI950319A priority patent/FI950319A0/fi
Priority to NO950318A priority patent/NO307407B1/no
Priority to GR990401188T priority patent/GR3030106T3/el
Priority to JP2005377119A priority patent/JP4976011B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
SE9202250A 1992-07-29 1992-07-29 Controlled release morphine preparation SE9202250D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9202250A SE9202250D0 (sv) 1992-07-29 1992-07-29 Controlled release morphine preparation
IL10647793A IL106477A (en) 1992-07-29 1993-07-26 Morphine salt preparations with controlled release
KR1019950700300A KR0156038B1 (ko) 1992-07-29 1993-07-28 방출 조절 모르핀 제제
JP6505225A JPH08501081A (ja) 1992-07-29 1993-07-28 制御放出モルヒネ製剤
DK93916380T DK0652747T3 (da) 1992-07-29 1993-07-28 Morfinpræparat med reguleret frigivelse
DE69323428T DE69323428T2 (de) 1992-07-29 1993-07-28 Morphinzubereitungen mit kontrollierter freisetzung
AT93916380T ATE176398T1 (de) 1992-07-29 1993-07-28 Morphinzubereitungen mit kontrollierter freisetzung
CA002140254A CA2140254C (en) 1992-07-29 1993-07-28 Controlled release morphine preparation
ES93916380T ES2130278T3 (es) 1992-07-29 1993-07-28 Preparacion de morfina de liberacion controlada.
NZ254314A NZ254314A (en) 1992-07-29 1993-07-28 Controlled release morphine preparation having a diffusion membrane coated core
PL93307262A PL172571B1 (pl) 1992-07-29 1993-07-28 Doustny preparat morfiny PL PL PL
HU9500260A HU221683B1 (hu) 1992-07-29 1993-07-28 Szabályozott hatóanyag-felszabadulást biztosító morfinkészítmény
PCT/SE1993/000642 WO1994003161A1 (en) 1992-07-29 1993-07-28 Controlled release morphine preparation
EP93916380A EP0652747B1 (en) 1992-07-29 1993-07-28 Controlled release morphine preparation
AU45955/93A AU662239B2 (en) 1992-07-29 1993-07-28 Controlled release morphine preparation
RU95105449A RU2114613C1 (ru) 1992-07-29 1993-07-28 Пероральный препарат морфина с регулируемым выделением активного компонента
ZA935488A ZA935488B (en) 1992-07-29 1993-07-29 Controlled release morphine preparation
CN93118344A CN1053339C (zh) 1992-07-29 1993-07-29 受控释放吗啡制剂
US08/362,526 US5520931A (en) 1992-07-29 1995-01-04 Controlled release morphine preparation
FI950319A FI950319A0 (fi) 1992-07-29 1995-01-25 Säädellyn vapautumisnopeuden omaava morfiinivalmiste
NO950318A NO307407B1 (no) 1992-07-29 1995-01-27 Morfinpreparat med kontrollert frigjøring
GR990401188T GR3030106T3 (en) 1992-07-29 1999-04-30 Controlled release morphine preparation.
JP2005377119A JP4976011B2 (ja) 1992-07-29 2005-12-28 制御放出モルヒネ製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202250A SE9202250D0 (sv) 1992-07-29 1992-07-29 Controlled release morphine preparation

Publications (1)

Publication Number Publication Date
SE9202250D0 true SE9202250D0 (sv) 1992-07-29

Family

ID=20386851

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202250A SE9202250D0 (sv) 1992-07-29 1992-07-29 Controlled release morphine preparation

Country Status (22)

Country Link
US (1) US5520931A (ru)
EP (1) EP0652747B1 (ru)
JP (2) JPH08501081A (ru)
KR (1) KR0156038B1 (ru)
CN (1) CN1053339C (ru)
AT (1) ATE176398T1 (ru)
AU (1) AU662239B2 (ru)
CA (1) CA2140254C (ru)
DE (1) DE69323428T2 (ru)
DK (1) DK0652747T3 (ru)
ES (1) ES2130278T3 (ru)
FI (1) FI950319A0 (ru)
GR (1) GR3030106T3 (ru)
HU (1) HU221683B1 (ru)
IL (1) IL106477A (ru)
NO (1) NO307407B1 (ru)
NZ (1) NZ254314A (ru)
PL (1) PL172571B1 (ru)
RU (1) RU2114613C1 (ru)
SE (1) SE9202250D0 (ru)
WO (1) WO1994003161A1 (ru)
ZA (1) ZA935488B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
GB2284760B (en) * 1993-11-23 1998-06-24 Euro Celtique Sa A method of preparing pharmaceutical compositions by melt pelletisation
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
GB2288117A (en) * 1994-03-01 1995-10-11 Euro Celtique Sa Sustained release morphine
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US5656291A (en) * 1994-03-16 1997-08-12 Pharmacia & Upjohn Aktiebolag Controlled release preparation
SE9301057L (sv) * 1993-03-30 1994-10-01 Pharmacia Ab Beredning med kontrollerad frisättning
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
IL109944A (en) † 1993-07-01 1998-12-06 Euro Celtique Sa Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
US6159501A (en) * 1996-03-08 2000-12-12 Nycomed Danmark A/S Modified release multiple-units dosage composition for release of opioid compounds
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) * 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
EP2263658A1 (en) 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
UA81224C2 (ru) * 2001-05-02 2007-12-25 Euro Celtic S A Дозированная форма оксикодона и ее применение
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
EP1429739A1 (en) 2001-09-21 2004-06-23 Egalet A/S Polymer release system
EP1450824A4 (en) * 2001-11-02 2005-09-28 Elan Corp Plc PHARMACEUTICAL COMPOSITION
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
AU2003272601B2 (en) * 2002-09-20 2009-05-07 Alpharma Pharmaceuticals, Llc Sustained-release opioid formulations and methods of use
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
WO2004041244A2 (en) * 2002-10-30 2004-05-21 Pharmacia Corporation Oral extended release tablets and methods of making and using the same
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
JP5269595B2 (ja) * 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US8161977B2 (en) 2006-01-31 2012-04-24 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CA2671200A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophilic abuse deterrent delivery system
US20080220064A1 (en) * 2006-12-06 2008-09-11 Ramesh Ketkar Anant Extended release matrix formulations of morphine
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
KR101492228B1 (ko) * 2007-07-26 2015-02-10 코와 가부시키가이샤 이브프로펜 및 트라넥사믹산 함유 고형제제
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
JP2015521988A (ja) 2012-07-06 2015-08-03 イガレット・リミテッド 制御放出用乱用防止性医薬組成物
WO2018208241A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation and optimization of controlled release tablets of morphine sulphate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE295548C (ru) *
US4461598A (en) * 1982-02-08 1984-07-24 Flechs Ronald D Machine for installing drip irrigation conduit
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
IE64726B1 (en) * 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法

Also Published As

Publication number Publication date
NO950318L (no) 1995-03-13
RU95105449A (ru) 1997-06-10
DK0652747T3 (da) 1999-09-20
HUT71527A (en) 1995-12-28
IL106477A (en) 1999-08-17
EP0652747B1 (en) 1999-02-03
FI950319A (fi) 1995-01-25
ES2130278T3 (es) 1999-07-01
AU662239B2 (en) 1995-08-24
JPH08501081A (ja) 1996-02-06
GR3030106T3 (en) 1999-07-30
AU4595593A (en) 1994-03-03
PL172571B1 (pl) 1997-10-31
HU9500260D0 (en) 1995-03-28
ZA935488B (en) 1994-02-28
JP2006096771A (ja) 2006-04-13
CA2140254A1 (en) 1994-02-17
NZ254314A (en) 1996-09-25
ATE176398T1 (de) 1999-02-15
JP4976011B2 (ja) 2012-07-18
PL307262A1 (en) 1995-05-15
DE69323428D1 (de) 1999-03-18
RU2114613C1 (ru) 1998-07-10
CN1053339C (zh) 2000-06-14
KR950702409A (ko) 1995-07-29
WO1994003161A1 (en) 1994-02-17
NO307407B1 (no) 2000-04-03
KR0156038B1 (ko) 1998-11-16
FI950319A0 (fi) 1995-01-25
DE69323428T2 (de) 1999-09-02
US5520931A (en) 1996-05-28
HU221683B1 (hu) 2002-12-28
NO950318D0 (no) 1995-01-27
EP0652747A1 (en) 1995-05-17
CA2140254C (en) 2004-01-20
CN1089472A (zh) 1994-07-20
IL106477A0 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
SE9202250D0 (sv) Controlled release morphine preparation
ATE67933T1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
MY101593A (en) Sustained release preparation.
DE3750145D1 (de) Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
CA2007181A1 (en) Sustained Release Pharmaceutical Composition
FI944961A0 (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
AR244089A1 (es) Metodo para la obtencion de una preparacion farmaceutica de liberacion sostenida.
HUP0203028A2 (hu) Tolterodint tartalmazó gyógyszerkészítmény és alkalmazása
DE69738185D1 (de) Verfahren zur Herstellung eines bluddrucksenkenden Mittel enthaltenden ein Dipeptid als wirksames Bestandteil